Clinical Trial: Role of Programmed Death Ligand 1 in Colorectal Cancer

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088341) titled 'Role of Programmed Death Ligand 1 in Colorectal Cancer' on July 19.

Brief Summary: 1. - Evaluation of diagnostic importance of soluble programmed death ligand-1 in patient with recently diagnosed as Colorectal cancer at different stages of disease .

2. Correlation of SPDL-1 level and clinco-pathological data of patients at presentation .

Study Start Date: Aug. 01

Study Type: OBSERVATIONAL

Condition: Colo-rectal Cancer

Intervention: DIAGNOSTIC_TEST: elisa

enzyme- linked immunesorbent assay ( ELISA ) was used to measure soluble programmed death ligand-1 level

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University...